Cognitive support - acetyl-L-carnitine (a form of carnitine) crosses the blood-brain barrier and supports memory
CGM improves A1C and reduces hypoglycemia Insulin pump (CSII): Preferred for Type 1 patients on multiple daily injections failing glycemic targets
Recalls & Warnings November 21, 2013 FDA Warns of Five More Weight Loss Supplements Containing Undeclared Drugs On November 21, 2013, the FDA warned consumers not to buy or use the following weight loss supplements because they were found to contain one or both of the undeclared drugs sibutramine and phenolphthalein: Recalls & Warnings December 12, 2014 Marketers of HCG Settle FTC Charges of Deceptive Weight Loss Claims Marketers of HCG Platinum drops have agreed to pay $1 million to settle Federal Trade Commission (FTC) charges that claims the drops could cause rapid and substantial weight loss were deceptive and not supported by scientific evidence
Taken together, current RCT and PRO data suggest that GLP-1RA treatment is associated with changes in eating experience, but remain insufficient to determine the specific functional level involved (sensory, liking, or wanting) or the long-term clinical significance of these changes
An overwhelming body of clinical evidence suggests that tirzepatide is superior to the anti-diabetic medication semaglutide with regards to improving blood sugar levels and reducing body weight: The comparison between Tirzepatide vs Ozempic highlights two distinct approaches to managing type 2 diabetes and weight, each with its own unique mechanisms and potential benefits
Exploration of Their Catalytic and Biochemical Potential
